Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

Therapeutic potential of glutaminyl cyclases: Current status and emerging trends - ScienceDirect

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals - Gunn - 2021 - Journal of Neurochemistry - Wiley Online Library

a Glutaminyl cyclase activity (mU/L): change from baseline at end of

RCSB PDB - 3SI1: Structure of glycosylated murine glutaminyl cyclase

PDF) Preparation of imidazolyl thiourea derivs. as glutaminyl cyclase inhibitors for treating cancer, nervous system disorders, and other diseases

Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design - ScienceDirect

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design

Full article: Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease